![]() | ![]() |
Formats:
|
||||||||||||
Copyright Achilli et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The Phylogeny of the Four Pan-American MtDNA Haplogroups: Implications for Evolutionary and Disease Studies 1Dipartimento di Genetica e Microbiologia, Università di Pavia, Pavia, Italy 2Dipartimento di Biologia Cellulare e Ambientale, Università degli Studi di Perugia, Perugia, Italy 3Sorenson Molecular Genealogy Foundation, Salt Lake City, Utah, United States of America 4Laboratorio de Genética Molecular Poblacional, Instituto Multidisciplinario de Biología Celular (IMBICE), La Plata, Argentina 5Armed Forces DNA Identification Laboratory, Armed Forces Institute of Pathology, Rockville, Maryland, United States of America 6Laboratory of Cellular and Molecular Evolution, and Molecular Biology of Domestic Animals, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China 7Laboratory for Conservation and Utilization of Bio-resource, Yunnan University, Kunming, China 8Unidade de Xenética, Instituto de Medicina Legal, Facultad de Medicina, Universidad de Santiago de Compostela, Grupo de Medicina Xenómica, Hospital Clínico Universitario, Santiago de Compostela, Galicia, Spain 9Department of Mathematics, University of Hamburg, Hamburg, Germany Vincent Macaulay, Academic Editor University of Glasgow, United Kingdom * To whom correspondence should be addressed. E-mail: torroni/at/ipvgen.unipv.it Conceived and designed the experiments: AS AT HB AA. Performed the experiments: AA UP. Analyzed the data: AS AT HB CB QK AA MC UP SW. Contributed reagents/materials/analysis tools: AT. Wrote the paper: AS AT HB CB QK AA MC UP SW. Received January 9, 2008; Accepted February 9, 2008. This article has been cited by other articles in PMC.Abstract Only a limited number of complete mitochondrial genome sequences belonging to Native American haplogroups were available until recently, which left America as the continent with the least amount of information about sequence variation of entire mitochondrial DNAs. In this study, a comprehensive overview of all available complete mitochondrial DNA (mtDNA) genomes of the four pan-American haplogroups A2, B2, C1, and D1 is provided by revising the information scattered throughout GenBank and the literature, and adding 14 novel mtDNA sequences. The phylogenies of haplogroups A2, B2, C1, and D1 reveal a large number of sub-haplogroups but suggest that the ancestral Beringian population(s) contributed only six (successful) founder haplotypes to these haplogroups. The derived clades are overall starlike with coalescence times ranging from 18,000 to 21,000 years (with one exception) using the conventional calibration. The average of about 19,000 years somewhat contrasts with the corresponding lower age of about 13,500 years that was recently proposed by employing a different calibration and estimation approach. Our estimate indicates a human entry and spread of the pan-American haplogroups into the Americas right after the peak of the Last Glacial Maximum and comfortably agrees with the undisputed ages of the earliest Paleoindians in South America. In addition, the phylogenetic approach also indicates that the pathogenic status proposed for various mtDNA mutations, which actually define branches of Native American haplogroups, was based on insufficient grounds. Introduction America was the last continent to be colonized by humans, and molecular data provided by different genetic systems [1], [2] have been extensively employed to shed light on the routes and times of human arrival and dispersion into the New World. As for mitochondrial DNA (mtDNA), it has been clear, since the early nineties, that mtDNAs of Native Americans could be traced back to four major haplogroups of Asian origin shared by North, Central and South American populations [3]–[7]. These were initially named A, B, C and D, and are now termed A2, B2, C1 and D1 [8]. Afterwards, a fifth haplogroup – now known as X2a – was described in Native Americans, but in contrast to the four “pan-American” haplogroups, its geographic distribution is restricted to some Amerindian populations of northern North America [8]–[12]. Later, two more haplogroups – D2a and D3 – were identified: D2a in the Aleuts and Eskimos [13], [14] and D3 only in the Eskimos [15], [16]. Most recently there were two further (uncommon) additions – D4h3 and C4c [14], [17] – bringing the total number of Native American haplogroups to nine. Since the early studies, the interpretation of mtDNA data has been rather controversial with scenarios postulating one to multiple migrational events from Beringia at very different times (between 11,000 and 40,000 years ago) (for a review, see [7]). Pinpointing an accurate timeframe for the arrival of the Native American founders would be essential to solve such a debate. Yet, accurate ages can only be based on large numbers of complete mitochondrial genomes, and American mtDNA haplogroups were only poorly represented in the total database of >3000 complete mtDNA sequences until very recently. Thus, despite the protagonist role of Native American mtDNAs in high-resolution mtDNA studies 15 years ago [4], America remained the continent from which we had the least information about the sequence variation of entire mtDNAs. Worse, the available information had to be retrieved from the web in a hit or miss fashion and suffers in part from improper documentation, oversights, and inadvertent nomenclature (Text S1). The overall situation is now beginning to change with some new data available in literature and public databases [14], [18], [19], but the interpretation of subsets of these data continue to remain controversial. For instance, the work by Tamm et al. [14] suggests that the Asian ancestors of the first Native Americans paused when they reached Beringia and that their (swift) migration southward might have occurred only ~13,500 years ago. Among the novel mtDNA sequences, there are 265 from “Hispanics” and “African-Americans” that recently became available in GenBank [19]. A survey of their variation reveals that 101 mtDNAs of Native American origin were included (47 belonging to haplogroups A2, 13 to B2, 30 to C1, and 11 to D1). Those mtDNAs are not associated with either a specific Native American population/tribe or a specific geographic region but are undoubtedly of Native American origin. Furthermore, due to the fact that these are all from individuals living in the US, they probably provide a fairly good overview of the mtDNA pool of extant or extinct Native American populations from North and Central America plus the Caribbean (due to the contribution of Mexicans, Puerto Ricans, Cubans, Salvadorans, etc. to the present-day US American population), and their analysis might provide important new clues about the process of human colonization of the Americas and the origin of Native Americans. Thus, the aim of this paper is not only to (i) perform a comprehensive analysis of all available complete (or almost complete) sequences of Native American ancestry belonging to the four major pan-American haplogroups, (ii) identify their internal clades and candidate founder sequences, and (iii) estimate their expansion times into the Americas, but also to (iv) provide a framework on which future phylogeographic studies, which remain scarce, can build upon. Results The phylogeny of pan-American haplogroups A2, B2, C1, and D1 To define the phylogeny of A2, B2, C1, and D1 at the highest level of molecular resolution – that of complete mtDNA sequences, it is necessary to evaluate (and possibly to expand) the current data set of published mtDNA sequences in regard to reliability as well as to update and correct the nomenclature (Text S1). Figure 1
The complete variation of all available mtDNA sequences belonging to haplogroups A2, B2, C1, and D1 is displayed in the phylogenies of Figures 2
The phylogeny of haplogroup B2 (Figure 3A As for haplogroup C1, all sequences appear to fall into one of the three subhaplogroups C1b, C1c, and C1d (Figure 3B As for D1 (Figure 3C Overall, the four phylogenies appear to be quite starlike, especially the B2 and D1 trees having high indices (~0.5) of starlikeness (Table 1). In the case of haplogroup C1, the three basal branches (C1b, C1c, and C1d) are themselves starlike, with the exception of C1b where a very low index of starlikeness (influencing also C1) is mainly due to an over-sampling (10 instances) of the root haplotype of the sub-branch C1b2a (sequences #107). The significance of starlike patterns in the Native American haplogroups would be that the successful propagation event of these haplogroups and some of their major branches (in Beringia or later on the move further south) can very well be dated assuming a reliable calibration of the mtDNA mutation rate. The point estimates for the coalescence times of haplogroups A2 (without the branches A2a and A2b), B2, C1 (without the Asian branch C1a), and D1 yield 18.1±1.8, 21.2±2.4, 23.8±4.3, and 18.6±2.3 ky, respectively, based on all 219 coding-region sequences (Table 1) and by employing the calibration of 1 coding-region substitution every 5,140 years [27]. The haplogroup ages thus fall into the range of 18–24 ky with an average of about 20.2 ky (Table 1). This value is a little bit lower (~19.0 ky) if the roots of the three branches of C1 (C1b, C1c and C1d), instead of C1 as a whole, are considered as Native American founders. This might be a (slight) underestimation because C1d is clearly under-represented in this study (comprising only eight mtDNAs). Thus, excluding C1d, the time frame is restricted to 18–21 ky and these estimates are about 1.4-fold higher than the larger time frame of 11–17 ky (A2: 13.9±2.0 ky; B2: 16.5±2.7 ky; C1b: 14.7±4.7 ky; C1c: 15.8±4.7 ky; D1: 10.8±2.0 ky) that was recently estimated [14] in a smaller dataset (105 mtDNA sequences) adopting a different calibration [26].
Detrimental mtDNA branches in Native Americans? In some of the newly defined Native American branches, one can identify mutations for which a pathogenic role was suggested in the medical literature. The seemingly ‘detrimental’ status of mutations G3316A and G13708A, defining haplogroups A2f and A2e respectively, has already been questioned and discussed at length in the East Asian mtDNA context [28]. The occurrence of both mutations is not infrequent (also appearing, for instance, in haplogroups B2 and D1) and therefore, not unexpectedly, they participate in the motifs of several haplogroups. A similar case is represented by the transition T1005C, which was proposed as a primary mutation for non-syndromic hearing loss [29], [30], and defines for instance the Asian haplogroup F2. In the context of Native American haplogroups, T1005C appears as a basal mutation of C1b5 – a branch of haplogroup C1b. Thus, all of these mutations are old and have been transmitted for at least some hundreds of generations. Although an effect of “old” mtDNA mutations in some multi-factorial/complex (and common) diseases cannot be ruled out a priori, a pathogenic role specific for such variants can, however, only be inferred from association studies in which haplogroup frequencies are properly evaluated in both patients and controls [31]. An extremely interesting case of a mutational motif marking a Native American branch of the mtDNA phylogeny is represented by the T3308A transversion with a subsequent insertion of one C (3308+C) that characterize haplogroup A2i. The insertion, first reported in a patient with dystonia, leads to a frameshift mutation for which a pathogenic role was proposed [32]. However, the other mutation of the motif – the T3308A transversion – eliminates the starting codon (methionine) of the ND1 subunit by converting it to lysine, thus paralleling the scenario first described for the T3308C transition that marks the African haplogroup L1b [33]. The finding that the elimination of the methionine codon AUA at position 1 of the ND1 subunit is polymorphic in some populations clearly indicates that the maintenance of that codon is not essential in our species, and therefore the insertion of one C at 3308 does not cause a frameshift for the entire gene. This is most likely due to the fact that the third codon (AUG) of the ND1 subunit also encodes for methionine, thus despite the shortening of two amino acids, ND1 could still retain its function. A different case is the one concerning the homoplasmic mutation T9205C detected in one mtDNA (no. 54) belonging to haplogroup A2 (Figure 2 Another illustrative case of hypothesized association between mtDNA mutations and a complex disorder is represented by the G1888A transition which could play some role in the pathogenesis of Type 2 diabetes [35] – a scenario that would be compatible with the well-known common-disease/common-polymorphism hypothesis. This transition is characteristic of both A2h and C1c, but is also present in West Eurasia, mainly in haplogroup T [36], and in South Asia, mainly on haplogroup M5 [37]. Unfortunately, the study of [35], similar to the most recent work [38], which again implicitly targeted haplogroup T, is absolutely insufficient to shield against population substructure influencing patient cohorts and control subjects in different ways. Especially in a country such as Brazil, matrilineal population substructure matters a lot across the country [39], as well as across social strata, which often correlate with continental matrilineal ancestry. Case-control association studies that do not consider the haplogroup context in which observed mutations are embedded do not allow an objective evaluation of the role played by mtDNA variants in disease expression either, because additional variables (such as social strata and ethnicity) may influence haplogroup frequencies (Text S3) [40]. Discussion The estimated ages (18–24 ky) of the four pan-American haplogroups A2, B2, C1, and D1 are quite similar with an average value of 20 ky. Thus, if A2, B2, C1, and D1 entered the Americas without variation in the coding region – in other words, each with only a single (successful) founder sequence (the root haplotype), their entry into the Americas would have occurred right after the peak of the Last Glacial Maximum (LGM, centered at ~21.0 kya and extending from 19.0 to at least 23.0 kya [41]), or slightly earlier, so that a coastal (Pacific) route would have been the only option during such glacial periods. On the other hand, it is quite plausible that some intra-haplogroup variation – hardly noticeable at the level of HVS-I motifs – already existed in Beringia and was carried directly further south into the American double-continent. If one assumes that at least the root haplotypes of A2, B2, D1, as well as of C1b, C1c, and C1d were of Beringian origin, then the entry time would come slightly down (19.0 kya), that is, falling exactly at the end of the LGM. Moreover, the relatively lower coalescence time (~17 ky) of the entire haplogroup A2 (Table 1) – including the shared sub-arctic branches A2b (Siberians and Inuits) and A2a (Siberians, Inuits and Na-Dené) [5], [14], [16], [18] – is probably due to secondary expansions of haplogroup A2 from Beringia long after the end of the LGM, which would have averaged the overall internal variation of haplogroup A2 in North America – the main source of the A2 mtDNAs in this study. In any case, all the abovementioned scenarios do not support the ‘Clovis-first’ hypothesis, but are well in agreement with the undisputed ages of the earliest Paleoindians in South America [42]. This conclusion would not change if one adopted the effectively faster rate of Kivisild et al. [26] based only on synonymous substitutions, which would generally shrink ages by a factor of ~3/4, as judged from a comparison with both the ages of the Native American haplogroups [14] and those of super-haplogroups L, L3, M, and N [43]. Therefore the main difference between both rates seems to concern only the absolute calibration as manifested in the estimated global coalescence times for super-haplogroup L. It is dubious whether the partial utilization of the coding-region information [14], [26] leads to more credible age estimates, taking into account the extremely low amount of synonymous mutation data characterizing younger clades, such as the Amerindian ones, and the extreme discrepancies with ages based on control-region variation of some haplogroups such as H, I, T, and U5 [44]. Moreover, if as suggested [26], the molecular clock did not apply to the entire coding region, but only to the synonymous mutations in the 13 genes coding for protein subunits, it would be rather unlikely that an age overlapping such as that reported for the well represented founder haplogroups (A2, B2, D1, C1b, and C1c) in Table 1 would be observed. In any case, with both clocks, a Beringian stage preceeding the expansion into the Americas – estimated at slightly different starting times and with a different duration depending on the clock employed – most likely took place, thus explaining the differentiation of the pan-American lineages from the Asian sister-clades (Figure 1 Our snapshot of the phylogenies for haplogroups A2, B2, C1, and D1 is only partially representative of Native American mtDNA variation, since most likely it only marginally includes the variation of Native American populations from Central and South America. However, despite this limitation, it is clear that one has to anticipate a pronounced starlike pattern near the root of each respective founder haplogroup/branch. The starlike pattern enhances the precision of the dating of the human entry into the Americas, but inevitably hinges upon the calibration employed and, perhaps more importantly, on a detailed founder analysis across the double-continent. Therefore it will require major sampling and sequencing efforts in the future for uncovering all of the most basal variation in the Native American mtDNA haplogroups by targeting, if possible, both the general mixed population of national states and autochthonous Native American groups, especially in Central and South America. A widespread knowledge of the specifics for the Native American haplogroups can also prevent the publishing of effectively mutilated or distorted mtDNA sequences from complete sequencing efforts in clinical studies [45], [46], but most importantly, the dissection of pan-American haplogroups into clades of younger age and more limited geographic and ethnic distributions is essential for reliable association studies between mtDNA haplogroups and complex disorders [31]. Materials and Methods The source of the sequence data (171 complete mtDNA sequences) employed for the phylogeny construction are listed in Table S1 (and Text S5), together with 14 novel Native American mtDNA sequences (four each belonging to haplogroups A2 and C1; three each belonging to B2 and D1) from the Dominican Republic (N = 4), Canada (N = 3) and United States (N = 7). The latter were completely sequenced as described elsewhere [47]. Additional 47 entire coding-region sequences [20], [26] were employed only for time estimation and inference of branching nodes (see also Text S4).The 101 complete mtDNA sequences [19] represent 13 of the 18 most common HVS-I & II haplotypes among the “Hispanic” component of the SWGDAM database [48]. Anonymous, unrelated samples were identified and obtained from either an internal Armed Forces DNA Identification Laboratory (AFDIL) database, or from 575 regional “Hispanics” living in the southern and northeastern regions of the US. The control region of their mtDNAs was then sequenced in order to determine the common HVS-I & II haplotypes [19]. Electronic database information Accession numbers and URLs for data presented herein are as follows: GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for the 14 novel complete mtDNA sequences [accession numbers EF079873-EF079876; EU431080-EU431089]); (for sequence no. 3 of Figure 1 Text S1 Mistakes, phantom mutations and discrepancies in literature and public databases (0.06 MB DOC) Click here for additional data file.(55K, doc) Text S2 Further information from mtDNA control-region and RFLP data (0.08 MB DOC) Click here for additional data file.(77K, doc) Text S3 Additional information concerning mtDNA disease studies (0.04 MB DOC) Click here for additional data file.(38K, doc) Text S4 (0.04 MB DOC) Click here for additional data file.(41K, doc) Table S1 Source of the complete mtDNA sequences (0.39 MB DOC) Click here for additional data file.(381K, doc) Acknowledgments We would also like to thank all the donors for providing biological specimen and the people involved in their collection. Footnotes Competing Interests: The authors have declared that no competing interests exist. Funding: This research received support from Progetti Ricerca Interesse Nazionale 2005 (Italian Ministry of the University) (to AT) and Fondazione Cariplo (to AT). Funding agencies had no role in the design and conduct of the study. References 1. Schurr TG, Sherry ST. Mitochondrial DNA and Y chromosome diversity and the peopling of the Americas: evolutionary and demographic evidence. Am J Hum Biol. 2004;16:420–439. [PubMed] 2. Wang S, Lewis CM, Jakobsson M, Ramachandran S, Ray N, et al. Genetic variation and population structure in Native Americans. PLoS Genet. 2007;3:e185. [PubMed] 3. Schurr TG, Ballinger SW, Gan YY, Hodge JA, Merriwether DA, et al. Amerindian mitochondrial DNAs have rare Asian mutations at high frequencies, suggesting they derived from four primary maternal lineages. Am J Hum Genet. 1990;46:613–623. [PubMed] 4. Torroni A, Schurr TG, Yang CC, Szathmary EJE, Williams RC, et al. Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics. 1992;130:153–162. [PubMed] 5. Torroni A, Schurr TG, Cabell MF, Brown MD, Neel JV, et al. Asian affinities and continental radiation of the four founding Native American mtDNAs. Am J Hum Genet. 1993;53:563–590. [PubMed] 6. Torroni A, Sukernik RI, Schurr TG, Starikorskaya YB, Cabell MF, et al. mtDNA variation of aboriginal Siberians reveals distinct genetic affinities with Native Americans. Am J Hum Genet. 1993;53:591–608. [PubMed] 7. Schurr TG. The peopling of the New World: perspectives from molecular anthropology. Annu Rev Anthropol. 2004;33:551–583. 8. Bandelt H-J, Herrnstadt C, Yao Y-G, Kong Q-P, Kivisild T, et al. Identification of Native American founder mtDNAs through the analysis of complete mtDNA sequences: some caveats. Ann Hum Genet. 2003;67:512–524. [PubMed] 9. Forster P, Harding R, Torroni A, Bandelt H-J. Origin and evolution of Native American mtDNA variation: a reappraisal. Am J Hum Genet. 1996;59:935–945. [PubMed] 10. Scozzari R, Cruciani F, Santolamazza P, Sellitto D, Cole DE, et al. mtDNA and Y chromosome-specific polymorphisms in modern Ojibwa: implications about the origin of their gene pool. Am J Hum Genet. 1997;60:241–244. [PubMed] 11. Brown MD, Hosseini SH, Torroni A, Bandelt H-J, Allen JC, et al. mtDNA haplogroup X: An ancient link between Europe/Western Asia and North America? Am J Hum Genet. 1998;63:1852–1861. [PubMed] 12. Reidla M, Kivisild T, Metspalu E, Kaldma K, Tambets K, et al. Origin and diffusion of mtDNA haplogroup X. Am J Hum Genet. 2003;73:1178–1190. [PubMed] 13. Derbeneva OA, Sukernik RI, Volodko NV, Hosseini SH, Lott MT, et al. Analysis of mitochondrial DNA diversity in the Aleuts of the Commander islands and its implications for the genetic history of Beringia. Am J Hum Genet. 2002;71:415–421. [PubMed] 14. Tamm E, Kivisild T, Reidla M, Metspalu M, Smith DG, et al. Beringian standstill and spread of Native American founders. PLoS ONE. 2007;2:e829. [PubMed] 15. Saillard J, Forster P, Lynnerup N, Bandelt H-J, Nørby S. mtDNA variation among Greenland Eskimos: the edge of the Beringian expansion. Am J Hum Genet. 2000;67:718–726. [PubMed] 16. Helgason A, Pálsson G, Pedersen HS, Angulalik E, Gunnarsdóttir ED, et al. mtDNA variation in Inuit populations of Greenland and Canada: migration history and population structure. Am J Phys Anthropol. 2006;130:123–134. [PubMed] 17. Kemp BM, Malhi RS, McDonough J, Bolnick DA, Eshleman JA, et al. Genetic analysis of early Holocene skeletal remains from Alaska and its implications for the settlement of the Americas. Am J Phys Anthropol. 2007;132:605–621. [PubMed] 18. Derenko M, Malyarchuk B, Grzybowski T, Denisova G, Dambueva I, et al. Phylogeographic analysis of mitochondrial DNA in northern Asian populations. Am J Hum Genet. 2007;81:1025–1041. [PubMed] 19. Parsons TJ. unpublished. http://www.ncjrs.gov/pdffiles1/nij/grants/213502.pdf. 20. Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet. 2002;70:1152–1171. [PubMed] 21. Accetturo M, Santamaria M, Lascaro D, Rubino F, Achilli A, et al. Human mtDNA site-specific variability values can act as haplogroup markers. Hum Mutat. 2006;27:965–974. [PubMed] 22. Herrnstadt C, Preston G, Howell N. Errors, phantoms and otherwise, in human mtDNA sequences. Am J Hum Genet. 2003;72:1585–1586. [PubMed] 23. Torroni A, Chen YS, Semino O, Santachiara-Beneceretti AS, Scott CR, et al. mtDNA and Y-chromosome polymorphisms in four Native American populations from southern Mexico. Am J Hum Genet. 1994;54:303–318. [PubMed] 24. Torroni A, Neel JV, Barrantes R, Schurr TG, Wallace DC. Mitochondrial DNA “clock” for the Amerinds and its implications for timing their entry into North America. Proc Natl Acad Sci U S A. 1994;91:1158–1162. [PubMed] 25. Álvarez-Iglesias V, Jaime JC, Carracedo Á, Salas A. Coding region mitochondrial DNA SNPs: Targeting East Asian and Native American haplogroups. Forensic Sci Int Genet. 2007;1:44–55. 26. Kivisild T, Shen P, Wall DP, Do B, Sung R, et al. The role of selection in the evolution of human mitochondrial genomes. Genetics. 2006;172:373–387. [PubMed] 27. Mishmar D, Ruiz-Pesini E, Golik P, Macaulay V, Clark AG, et al. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A. 2003;100:171–176. [PubMed] 28. Kong Q-P, Bandelt H-J, Sun C, Yao Y-G, Salas A, et al. Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet. 2006;15:2076–2086. [PubMed] 29. Li Z, Li R, Chen J, Liao Z, Zhu Y, et al. Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss. Hum Genet. 2005;117:9–15. [PubMed] 30. Yao Y-G, Salas A, Bravi CM, Bandelt H-J. A reappraisal of complete mtDNA variation in East Asian families with hearing impairment. Hum Genet. 2006;119:505–515. [PubMed] 31. Carelli V, Achilli A, Valentino ML, Rengo C, Semino O, et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet. 2006;78:564–574. [PubMed] 32. Simon DK, Tarnopolsky MA, Greenamyre JT, Johns DR. A frameshift mitochondrial complex I gene mutation in a patient with dystonia and cataracts: is the mutation pathogenic? J Med Genet. 2001;38:58–61. [PubMed] 33. Rocha H, Flores C, Campos Y, Arenas J, Vilarinho L, et al. About the “pathological” role of the mtDNA T3308C mutation… Am J Hum Genet. 1999;65:1457–1459. [PubMed] 34. MITOMAP: A Human Mitochondrial Genome Database. http://www.mitomap.org. 35. Crispim D, Canani LH, Gross JL, Carlessi RM, Tschiedel B, et al. The G1888A variant in the mitochondrial 16S rRNA gene may be associated with Type 2 diabetes in Caucasian-Brazilian patients from southern Brazil. Diabet Med. 2005;22:1683–1689. [PubMed] 36. Palanichamy Mg, Sun C, Agrawal S, Bandelt H-J, Kong Q-P, et al. Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet. 2004;75:966–978. [PubMed] 37. Sun C, Kong Q-P, Palanichamy Mg, Agrawal S, Bandelt H-J, et al. The dazzling array of basal branches in the mtDNA macrohaplogroup M from India as inferred from complete genomes. Mol Biol Evol. 2006;23:683–690. [PubMed] 38. Crispim D, Canani LH, Gross JL, Tschiedel B, Souto KE, et al. The European-specific mitochondrial cluster J/T could confer an increased risk of insulin-resistance and type 2 diabetes: an analysis of the m.4216T > C and m.4917A > G variants. Ann Hum Genet. 2006;70:488–495. [PubMed] 39. Alves-Silva J, da Silva Santos M, Guimarães PE, Ferreira AC, Bandelt H-J, et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet. 2000;67:444–461. [PubMed] 40. Mosquera-Miguel A, Álvarez-Iglesias V, Vega A, Milne R, Cabrera de León A, et al. Is mitochondrial DNA variation associated with sporadic breast cancer risk? Cancer Res. 2008 in press. 41. Mix AC, Bard E, Schneider R. Environmental processes of the ice age: land, oceans, glaciers (EPILOG). Quaternary Science Reviews. 2001;20:627–657. 42. Waters MR, Stafford TW., Jr. Redefining the age of Clovis: implications for the peopling of the Americas. Science. 2007;315:1122–1126. [PubMed] 43. Macaulay V, Hill C, Achilli A, Rengo C, Clarke D, et al. Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes. Science. 2005;308:1034–1036. [PubMed] 44. Richards M, Macaulay V, Hickey E, Vega E, Sykes B, et al. Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet. 2000;67:1251–1276. [PubMed] 45. Bandelt H-J, Achilli A, Kong Q-P, Salas A, Lutz-Bonengel S, et al. Low “penetrance” of phylogenetic knowledge in mitochondrial disease studies. Biochem Biophys Res Commun. 2005;333:122–130. [PubMed] 46. Bandelt H-J, Yao Y-G, Salas A, Kivisild T, Bravi CM. High penetrance of sequencing errors and interpretative shortcomings in mtDNA sequence analysis of LHON patients. Biochem Biophys Res Commun. 2007;352:283–291. [PubMed] 47. Achilli A, Rengo C, Magri C, Battaglia V, Olivieri A, et al. The molecular dissection of mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the European gene pool. Am J Hum Genet. 2004;75:910–918. [PubMed] 48. Monson KL, Miller KWP, Wilson MR, DiZinno JA, Budowle B. The mtDNA Population Database: an integrated software and database resource for forensic comparison. Forensic Sci Commun. 2002;4:2. 49. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 1999;23:147. [PubMed] 50. Bandelt H-J, Parson W. Consistent treatment of length variants in the human mtDNA control region: a reappraisal. Int J Legal Med. 2008;122:11–21. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Am J Hum Biol. 2004 Jul-Aug; 16(4):420-39.
[Am J Hum Biol. 2004]PLoS Genet. 2007 Nov; 3(11):e185.
[PLoS Genet. 2007]Am J Hum Genet. 1990 Mar; 46(3):613-23.
[Am J Hum Genet. 1990]Ann Hum Genet. 2003 Nov; 67(Pt 6):512-24.
[Ann Hum Genet. 2003]Am J Hum Genet. 2003 Nov; 73(5):1178-90.
[Am J Hum Genet. 2003]Genetics. 1992 Jan; 130(1):153-62.
[Genetics. 1992]PLoS One. 2007 Sep 5; 2(9):e829.
[PLoS One. 2007]Am J Hum Genet. 2007 Nov; 81(5):1025-41.
[Am J Hum Genet. 2007]Ann Hum Genet. 2003 Nov; 67(Pt 6):512-24.
[Ann Hum Genet. 2003]Am J Hum Genet. 1996 Oct; 59(4):935-45.
[Am J Hum Genet. 1996]Am J Hum Genet. 2003 Nov; 73(5):1178-90.
[Am J Hum Genet. 2003]Am J Hum Genet. 2000 Sep; 67(3):718-26.
[Am J Hum Genet. 2000]Am J Hum Genet. 2002 May; 70(5):1152-71.
[Am J Hum Genet. 2002]Nat Genet. 1999 Oct; 23(2):147.
[Nat Genet. 1999]Am J Phys Anthropol. 2006 May; 130(1):123-34.
[Am J Phys Anthropol. 2006]Am J Hum Genet. 2002 Aug; 71(2):415-21.
[Am J Hum Genet. 2002]Am J Hum Genet. 2007 Nov; 81(5):1025-41.
[Am J Hum Genet. 2007]Am J Hum Genet. 1993 Sep; 53(3):563-90.
[Am J Hum Genet. 1993]Hum Mutat. 2006 Sep; 27(9):965-74.
[Hum Mutat. 2006]Am J Hum Genet. 2002 May; 70(5):1152-71.
[Am J Hum Genet. 2002]Am J Hum Genet. 2003 Jun; 72(6):1585-6.
[Am J Hum Genet. 2003]Am J Hum Genet. 1993 Sep; 53(3):563-90.
[Am J Hum Genet. 1993]Am J Hum Genet. 1994 Feb; 54(2):303-18.
[Am J Hum Genet. 1994]Am J Hum Genet. 2004 Nov; 75(5):910-8.
[Am J Hum Genet. 2004]Am J Hum Genet. 1993 Sep; 53(3):563-90.
[Am J Hum Genet. 1993]Am J Hum Genet. 1994 Feb; 54(2):303-18.
[Am J Hum Genet. 1994]PLoS One. 2007 Sep 5; 2(9):e829.
[PLoS One. 2007]Proc Natl Acad Sci U S A. 1994 Feb 1; 91(3):1158-62.
[Proc Natl Acad Sci U S A. 1994]PLoS One. 2007 Sep 5; 2(9):e829.
[PLoS One. 2007]Genetics. 2006 Jan; 172(1):373-87.
[Genetics. 2006]Proc Natl Acad Sci U S A. 2003 Jan 7; 100(1):171-6.
[Proc Natl Acad Sci U S A. 2003]PLoS One. 2007 Sep 5; 2(9):e829.
[PLoS One. 2007]Genetics. 2006 Jan; 172(1):373-87.
[Genetics. 2006]Am J Hum Biol. 2004 Jul-Aug; 16(4):420-39.
[Am J Hum Biol. 2004]Am J Hum Genet. 1990 Mar; 46(3):613-23.
[Am J Hum Genet. 1990]PLoS Genet. 2007 Nov; 3(11):e185.
[PLoS Genet. 2007]Genetics. 1992 Jan; 130(1):153-62.
[Genetics. 1992]Genetics. 1992 Jan; 130(1):153-62.
[Genetics. 1992]Am J Hum Genet. 1993 Sep; 53(3):563-90.
[Am J Hum Genet. 1993]Am J Hum Genet. 1993 Sep; 53(3):591-608.
[Am J Hum Genet. 1993]Hum Mol Genet. 2006 Jul 1; 15(13):2076-86.
[Hum Mol Genet. 2006]Hum Genet. 2005 Jun; 117(1):9-15.
[Hum Genet. 2005]Hum Genet. 2006 Jun; 119(5):505-15.
[Hum Genet. 2006]Am J Hum Genet. 2006 Apr; 78(4):564-74.
[Am J Hum Genet. 2006]J Med Genet. 2001 Jan; 38(1):58-61.
[J Med Genet. 2001]Am J Hum Genet. 1999 Nov; 65(5):1457-9.
[Am J Hum Genet. 1999]Diabet Med. 2005 Dec; 22(12):1683-9.
[Diabet Med. 2005]Am J Hum Genet. 2004 Dec; 75(6):966-78.
[Am J Hum Genet. 2004]Mol Biol Evol. 2006 Mar; 23(3):683-90.
[Mol Biol Evol. 2006]Ann Hum Genet. 2006 Jul; 70(Pt 4):488-95.
[Ann Hum Genet. 2006]Am J Hum Genet. 2000 Aug; 67(2):444-61.
[Am J Hum Genet. 2000]Am J Hum Genet. 1993 Sep; 53(3):563-90.
[Am J Hum Genet. 1993]PLoS One. 2007 Sep 5; 2(9):e829.
[PLoS One. 2007]Am J Phys Anthropol. 2006 May; 130(1):123-34.
[Am J Phys Anthropol. 2006]Am J Hum Genet. 2007 Nov; 81(5):1025-41.
[Am J Hum Genet. 2007]Science. 2007 Feb 23; 315(5815):1122-6.
[Science. 2007]Genetics. 2006 Jan; 172(1):373-87.
[Genetics. 2006]PLoS One. 2007 Sep 5; 2(9):e829.
[PLoS One. 2007]Science. 2005 May 13; 308(5724):1034-6.
[Science. 2005]Am J Hum Genet. 2000 Nov; 67(5):1251-76.
[Am J Hum Genet. 2000]Biochem Biophys Res Commun. 2005 Jul 22; 333(1):122-30.
[Biochem Biophys Res Commun. 2005]Biochem Biophys Res Commun. 2007 Jan 12; 352(2):283-91.
[Biochem Biophys Res Commun. 2007]Am J Hum Genet. 2006 Apr; 78(4):564-74.
[Am J Hum Genet. 2006]Am J Hum Genet. 2004 Nov; 75(5):910-8.
[Am J Hum Genet. 2004]Am J Hum Genet. 2002 May; 70(5):1152-71.
[Am J Hum Genet. 2002]Genetics. 2006 Jan; 172(1):373-87.
[Genetics. 2006]